First-time generic approval May 2011

News
Article

Generic drug approved by FDA (through May 2011): Latanoprost

Latanoprost ophthalmic solution, 0.005% (eqiv. to Xalatan)
MYLAN

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!
Recent Videos
Related Content
driftwood-stock@adobe.com

Medicare Plans Face Higher Liability From Cap on Out-of-Pocket Drug Costs

Denise Myshko
August 15th 2025
Article

Read More

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Nancy Lurker of EyePoint Pharmaceuticals Addresses Innovations in Eye Care, How to Grow in the C-Suite and What it Takes to Run a Biopharma Company

Briana Contreras
August 15th 2025
Podcast

Listen

Valeri Luzina-stock@adobe.com

Employers Project 10% Rise in Healthcare Costs for 2026

Denise Myshko
August 15th 2025
Article

Read More

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

David Calabrese of OptumRx Talks Top Three Drugs in Pipeline, Industry Trends in Q2

Briana Contreras
August 15th 2025
Podcast

Listen

FDA Approves First Treatment for Chronic Inflammatory Lung Condition

FDA Approves First Treatment for Chronic Inflammatory Lung Condition

Denise Myshko
August 15th 2025
Article

Read More

Preserving the History of Retina, One Narrative at a Time

Preserving the History of Retina, One Narrative at a Time

Denise Myshko
August 15th 2025
Article

Read More

© 2025 MJH Life Sciences

All rights reserved.